IN BRIEF: Aptamer signs Optimer contract with US biotech Alphazyme
Aptamer Group PLC - York, England-based synthetic binders developer - Strikes licensing agreement with Alphazyme Inc. This grants Jupiter, Florida-based biotechnology company Alphazyme a non-exclusive licence for use of an enzyme-modulating Optimer in hot-start polymerase chain reaction and next-generation sequencing applications within Alphazyme's own products and services. Optimer binders are advanced molecules that work like antibodies by attaching to specific targets in the body. Read More